IRMD News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

IR

Mkt Cap

$1.14B

Volume

67.76K

Next Earnings

November 2nd

Chart Financials Earnings News About Dividends Insider Filings

IRadimed (IRMD) Q2 2026 Earnings Call TranscriptIRadimed reported Q2 2026 revenue of $20.5 million (up 0.5% YoY) with gross margins compressed to 74% from 78% due to manufacturing inefficiencies during the first production ramp of the new 3870 MRI-compatible pump. The company achieved its manufacturing target of 130-135 units and plans to more than double production to over 300 units in Q3. Strong customer demand drove bookings more than double shipments, with 70% of replacements being quad (4-channel) systems at $110,000+ ASP. Management reaffirmed full-year 2026 guidance of $91-96 million revenue and $2.09-2.24 non-GAAP EPS, expecting margin recovery as manufacturing efficiencies improve.The Motley Fool · Aug 8, 2026

IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving ItIRADIMED CEO Roger E. Susi sold 7,500 shares indirectly through a trust for approximately $691,000 as part of a systematic Rule 10b5-1 plan. The sale represents routine liquidation rather than a negative signal, with the stock up 60.89% over the past year. The key investment variable is the adoption of the company's new infusion pump, with meaningful data expected by mid-2027.The Motley Fool · Jun 2, 2026

Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.Iradimed CEO Roger Susi sold 7,500 shares worth ~$694,125 on April 20-21, 2026, as part of a Rule 10b5-1 trading plan adopted in November 2025. The sale is not concerning as it follows a systematic pattern and Susi retains over 4 million shares. Iradimed's strong business performance—with 2025 sales up 14% to $83.8M and net income reaching $22.5M—has driven the stock up 78% over one year, though the elevated forward P/E of 42 suggests waiting for a price dip before buying.The Motley Fool · Apr 28, 2026

IRADIMED CORPORATION to Participate at the 38th Annual Roth ConferenceIRADIMED CORPORATION announced its participation in the 38th Annual Roth Conference on March 22 and 24, 2026, at the Ritz-Carlton in Laguna Niguel, CA. CEO Roger Susi and CFO Jack Glenn will host one-on-one meetings with investors. The company is a leader in MRI-compatible medical devices, including its patented MRidium® IV infusion pump system and 3880 patient vital signs monitoring system.GlobeNewswire Inc. · Mar 16, 2026

Why Iradimed Stock Soared TodayIradimed Corporation's stock surged 9.26% after reporting its 18th consecutive quarter of record revenue at $22.7 million (up 17% YoY) and beating adjusted net income estimates at $0.54 per share versus $0.48 expected. The medical device maker, which specializes in MRI-compatible infusion pump systems, launched a new product and raised its quarterly dividend from $0.17 to $0.20 per share. The company provided 2026 guidance of $91-96 million in revenue and $2.06-2.21 adjusted net income per share.The Motley Fool · Feb 10, 2026

Baker Hughes Digital Transformation Strategy and Innovation Programs 2024Baker Hughes, an energy technology company, has two segments: Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET). The report provides insights into the company's digital transformation strategies, innovation programs, and technology initiatives.GlobeNewswire Inc. · Nov 18, 2024

Well Intervention Market to Drive Growth at USD 12.14 Billion by 2031 | SkyQuest TechnologyThe global well intervention market is projected to reach USD 12.14 Billion by 2031, driven by new oilfield developments, rising energy demand, and the need to maintain the integrity of aging oil and gas wells. The market is expected to grow at a CAGR of 4.8% during the forecast period.Benzinga · Nov 14, 2024

IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global MarketTrading to commence effective on the market open June 14, 2024 Trading to commence effective on the market open June 14, 2024GlobeNewswire Inc. · Jun 7, 2024

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2ndWINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.GlobeNewswire Inc. · Apr 25, 2024

IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceIRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceGlobeNewswire Inc. · Mar 13, 2024

IR

IRMDiRadimed Corporation

IRMD

Pay with—

Available Balance0.00

Your PositionYou don't own any IRMD yet.

Related Tickers

Earnings

Dividends

Last · Aug 14Quarterly

Amount$0.20

Yield1.44%

Annual$1.27